Synergistic inhibition of colon cancer cell growth by a combination of atorvastatin and phloretin

  • Authors:
    • Mo Zhou
    • Jinkai Zheng
    • Jinfeng Bi
    • Xinye Wu
    • Jian Lyu
    • Kun Gao
  • View Affiliations

  • Published online on: November 23, 2017     https://doi.org/10.3892/ol.2017.7480
  • Pages:1985-1992
Metrics: HTML 0 views | PDF 0 views     Cited By (CrossRef): 0 citations

Abstract

Atorvastatin (ATST), a drug commonly used to reduce the levels of cholesterol and low‑density lipoproteins, is a prospective agent for the prevention of colorectal cancer in patients with hyperlipidemia. ATST in combination with functional components is a promising strategy for cancer chemoprevention. In the present study, the growth inhibitory effect of ATST combined with phloretin (PT) on SW620 and HCT116 colon cancer cells was investigated. The results of MTT assays indicated that the combination of PT and ATST markedly reduced cell survival in both cell lines compared with PT or ATST treatment administered individually. The interaction indexes between PT and ATST, which were used to analyze their interaction pattern, were computed by the median‑effect equation. The interaction indexes of each PT and ATST concentration pair were <1.0, which indicated a strong synergistic effect between the two compounds. The data obtained by flow cytometry and western blot analysis of cleaved‑poly (ADP‑ribose) polymerase indicated a synergistic effect resulted in apoptosis and cell cycle arrest at the G2/M checkpoint. Furthermore, combined treatment with PT and ATST markedly downregulated the expression of cyclin B and upregulated the expression of phospho‑cdc2 and Myt1, which suggested that the activation of cdc2 was downregulated. This combined treatment strategy enhanced the anti‑cancer activity of ATST at a relatively low dosage and suggested a possible method of preventing colorectal cancer in patients with hyperlipidemia.

Related Articles

Journal Cover

February 2018
Volume 15 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Zhou, M., Zheng, J., Bi, J., Wu, X., Lyu, J., & Gao, K. (2018). Synergistic inhibition of colon cancer cell growth by a combination of atorvastatin and phloretin. Oncology Letters, 15, 1985-1992. https://doi.org/10.3892/ol.2017.7480
MLA
Zhou, M., Zheng, J., Bi, J., Wu, X., Lyu, J., Gao, K."Synergistic inhibition of colon cancer cell growth by a combination of atorvastatin and phloretin". Oncology Letters 15.2 (2018): 1985-1992.
Chicago
Zhou, M., Zheng, J., Bi, J., Wu, X., Lyu, J., Gao, K."Synergistic inhibition of colon cancer cell growth by a combination of atorvastatin and phloretin". Oncology Letters 15, no. 2 (2018): 1985-1992. https://doi.org/10.3892/ol.2017.7480